Grant: Undergraduate: Summer Studentship Award - Institute Community Support
McMaster University
$5,000.00
Investigating the role of System xC(-) in statin-induced muscle pain
FY 2018-19
Summary
Statins are a class of drugs that are used to manage high-cholesterol and reduce the risk of cardiovascular disease. It is estimated that approximately 10% of Canadians have been prescribed statins, and even more should be on them. While these drugs have proven to be highly effective and generally have a favourable safety profile, one of the most commonly reported side effects is muscle pain (myalgia). Statin-induced myalgia is leading cause of non-compliance and discontinuation of statin treatment; however, the cause of these symptoms remains largely unknown. In this proposed study, we aim to understand the biological mechanism underlying muscle pain in statin therapy. This fundamental knowledge will provide the basis for novel drug development that can treat high cholesterol and reduce the risk of cardiovascular disease, while minimizing the incidence of adverse events. This research will also help to identify people at risk of more serious muscle complications in statin therapy.
Department
Program
Undergraduate: Summer Studentship Award - Institute Community Support
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
400557
Name
Martin Grace
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Summer Studentships in Musculoskeletal Health
Projecttitle
Investigating the role of System xC(-) in statin-induced muscle pain
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Summer Studentship Award - Institute Community Support
Keyworddelim
Myalgia; Myopathy; Skeletal Muscle; Statin-Induced Myalgia; System Xc(-)
Abstract
Statins are a class of drugs that are used to manage high-cholesterol and reduce the risk of cardiovascular disease. It is estimated that approximately 10% of Canadians have been prescribed statins, and even more should be on them. While these drugs have proven to be highly effective and generally have a favourable safety profile, one of the most commonly reported side effects is muscle pain (myalgia). Statin-induced myalgia is leading cause of non-compliance and discontinuation of statin treatment; however, the cause of these symptoms remains largely unknown. In this proposed study, we aim to understand the biological mechanism underlying muscle pain in statin therapy. This fundamental knowledge will provide the basis for novel drug development that can treat high cholesterol and reduce the risk of cardiovascular disease, while minimizing the incidence of adverse events. This research will also help to identify people at risk of more serious muscle complications in statin therapy.
Competitiondate
201901
Approvedterm2
0 yr 4 mths
Pinamesdelim
Martin, Grace
Approvedterm
0 an 4 mois
Cihrcontribution2
~ $5,000~ $0~